| GALECTIN THERA. DL-,01 |
| USA |
| Gesundheit |
| US3632252025 / A1JV3R |
| PHPN (Frankfurt) / GALT (NASDAQ) |
| FRA:PHPN, ETR:PHPN, PHPN:GR, NASDAQ:GALT |
| - |
| http://www.galectintherap.. |
|
Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for fibrotic disease, cancer, and selected other chronic conditions. Galectin Therapeutics uses a carbohydrate-based approach centered on galecti..
>Volltext.. |
| 279.07 Mio. EUR |
| 390.32 Mio. EUR |
| - |
| -14.12 Mio. EUR |
| -25.26 Mio. EUR |
| -0.39 EUR |
| 124.99 Mio. EUR |
| 12.04 Mio. EUR |
| -14.42 Mio. EUR |
| 0.09 |
| - |
| 28.81% |
| - |
| - |
| - |
| - |
| GALECTIN |
| 16.11.26 |
|